Keywords: crucell, licenses, permexis, lonza, switzerland-based, custom, peptide

Crucell licenses PERMEXIS to Lonza

Article | 06 October 2008

Switzerland-based custom peptide manufacturer Lonza and Dutch biotechnology company Crucell have entered into a co-exclusive manufacturing, sales and distribution agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lonza

Go to company listing